These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2059 related articles for article (PubMed ID: 11363525)

  • 1. Letter to the editor. [letter].
    Hsu A; Kempf D; Leonard J; Mills R
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):60. PubMed ID: 11363525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
    Schouten JT
    STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of drug cocktail combinations for their immunological value in preventing/remitting opportunistic infections.
    Konlee M
    Posit Health News; 1998; (No 16):2-4. PubMed ID: 11365016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ritonavir, Abbott protease inhibitor, approved.
    AIDS Treat News; 1996 Mar; (no 243):2-3. PubMed ID: 11363300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA approves nelfinavir. Food and Drug Administration.
    GMHC Treat Issues; 1997 Mar; 11(3):8. PubMed ID: 11364277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delavirdine dilemma at the FDA. Food and Drug Administration.
    Smart T
    GMHC Treat Issues; 1996 Dec; 10(12):4-5. PubMed ID: 11364017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Norvir soft-gel capsule formulation approved by FDA.
    Gaylord G
    Posit Living; 1999 Aug; 8(7):11. PubMed ID: 12492076
    [No Abstract]   [Full Text] [Related]  

  • 8. Protease inhibitors and anticonvulsants.
    Brooks J; Daily J; Schwamm L
    AIDS Clin Care; 1997 Nov; 9(11):87, 90. PubMed ID: 11364776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA notifications. FDA approves new Kaletra formulation.
    AIDS Alert; 2005 Dec; 20(12):142-3. PubMed ID: 16400722
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA issues warning letter to Abbott over Norvir pricing spin.
    GMHC Treat Issues; 2004; 18(5-6):11. PubMed ID: 15359439
    [No Abstract]   [Full Text] [Related]  

  • 11. Kaletra OK'd by FDA.
    James JS
    Posit Living; 2000 Nov; 9(9):8, 13. PubMed ID: 12154764
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA notifications. FDA approves NDA for Lexiva.
    AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415960
    [No Abstract]   [Full Text] [Related]  

  • 13. Nelfinavir: fourth protease inhibitor approved.
    Crit Path AIDS Proj; 1997; (No 32):31-2. PubMed ID: 11364442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drug approved to treat HIV.
    Treat Rev; 1997 Apr; (No 24):5. PubMed ID: 11364284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New formulation of saquinavir (Fortovase) is more effective.
    Tam CW
    Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitor approvals: will people be cut off drug? Followup studies proposal needs support.
    James JS
    AIDS Treat News; 1996 Mar; (no 242):3. PubMed ID: 11363191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA approves new dosing for amprenavir and ritonavir combination.
    AIDS Treat News; 2002 Mar; (378):6-7. PubMed ID: 11965920
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA approves first new class of HIV drugs. Food and Drug Administration.
    AIDS Alert; 1996 Aug; 11(8):89. PubMed ID: 11363655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric treatments.
    AIDS Policy Law; 1997 Apr; 12(6):12. PubMed ID: 11364179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nelfinavir (Viracept) approved: fourth protease inhibitor available.
    James JS
    AIDS Treat News; 1997 Mar; (No 267):1-2. PubMed ID: 11364249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 103.